Humacyte Inc (HUMA) — Financial Flexibility Index

Latest as of December 2025: -0.23x

Humacyte Inc (HUMA) has a Financial Flexibility Index of -0.23x as of December 2025. Free cash flow of $-26.08 Million (operating CF $-26.12 Million minus capex $39.00K) represents 0% of total liabilities ($113.26 Million). Also explore HUMA shareholders equity momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-26.08 Million
Operating CF − Capex

Total Liabilities

$113.26 Million
USD

Capital Expenditures

$39.00K
USD

Humacyte Inc Financial Flexibility Index (2019–2025)

Historical Financial Flexibility Index trend for Humacyte Inc across 7 annual periods. Check how strategically is Humacyte Inc's equity deployed to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Humacyte Inc (2019–2025)

Year-by-year free cash flow to debt coverage for Humacyte Inc. For the full company profile including market capitalisation, see HUMA stock market capitalisation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.92x $-104.16 Million $-105.04 Million $113.26 Million ▼ -81.5%
2024 -0.51x $-96.55 Million $-98.12 Million $190.54 Million ▲ +18.2%
2023 -0.62x $-71.03 Million $-73.31 Million $114.68 Million ▲ +22.8%
2022 -0.80x $-70.08 Million $-71.13 Million $87.37 Million ▼ -62.8%
2021 -0.49x $-80.97 Million $-81.19 Million $164.36 Million ▲ +67.9%
2020 -1.53x $-55.25 Million $-55.57 Million $36.02 Million ▲ +12.1%
2019 -1.74x $-63.66 Million $-71.79 Million $36.49 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities